Regeneron Pharmaceuticals (REGN) Times Interest Earned (2017 - 2025)
Historic Times Interest Earned for Regeneron Pharmaceuticals (REGN) over the last 16 years, with Q4 2025 value amounting to $72.12.
- Regeneron Pharmaceuticals' Times Interest Earned fell 2352.14% to $72.12 in Q4 2025 from the same period last year, while for Dec 2025 it was $81.69, marking a year-over-year increase of 1299.11%. This contributed to the annual value of $81.69 for FY2025, which is 1299.11% up from last year.
- Per Regeneron Pharmaceuticals' latest filing, its Times Interest Earned stood at $72.12 for Q4 2025, which was down 2352.14% from $53.2 recorded in Q3 2025.
- In the past 5 years, Regeneron Pharmaceuticals' Times Interest Earned ranged from a high of $299.86 in Q2 2025 and a low of $46.67 during Q1 2024
- Its 5-year average for Times Interest Earned is $98.15, with a median of $74.24 in 2021.
- In the last 5 years, Regeneron Pharmaceuticals' Times Interest Earned crashed by 6479.51% in 2022 and then skyrocketed by 31491.63% in 2025.
- Quarter analysis of 5 years shows Regeneron Pharmaceuticals' Times Interest Earned stood at $187.21 in 2021, then plummeted by 64.8% to $65.91 in 2022, then fell by 19.34% to $53.16 in 2023, then soared by 77.38% to $94.3 in 2024, then fell by 23.52% to $72.12 in 2025.
- Its Times Interest Earned was $72.12 in Q4 2025, compared to $53.2 in Q3 2025 and $299.86 in Q2 2025.